Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (550)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2025
3050
8.920
Why?
Hematopoietic Stem Cell Transplantation
28
2024
606
3.460
Why?
Pyrazines
20
2023
190
2.580
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1031
2.430
Why?
Boronic Acids
19
2014
183
2.400
Why?
Thalidomide
28
2023
378
2.370
Why?
Transplantation, Autologous
30
2024
488
1.900
Why?
Antineoplastic Agents
30
2020
1221
1.880
Why?
Transplantation Conditioning
9
2019
93
1.420
Why?
Drug Resistance, Neoplasm
17
2020
327
1.410
Why?
Paraproteinemias
8
2018
74
1.240
Why?
Neoplastic Stem Cells
5
2020
93
1.160
Why?
Humans
158
2025
52593
1.160
Why?
Protease Inhibitors
6
2011
59
1.040
Why?
Venous Thrombosis
7
2009
90
1.010
Why?
Melphalan
16
2023
181
0.970
Why?
Stem Cell Transplantation
13
2023
187
0.970
Why?
Angiogenesis Inhibitors
9
2009
184
0.970
Why?
Plasma Cells
12
2025
239
0.950
Why?
Aged
59
2025
10191
0.940
Why?
Prognosis
34
2025
2118
0.930
Why?
Gene Expression Regulation, Neoplastic
13
2020
857
0.910
Why?
Hematopoietic Stem Cell Mobilization
5
2014
60
0.910
Why?
Middle Aged
61
2025
13096
0.870
Why?
Alkaline Phosphatase
5
2011
93
0.820
Why?
Busulfan
3
2019
17
0.820
Why?
Treatment Outcome
39
2022
5486
0.760
Why?
Dexamethasone
16
2024
440
0.730
Why?
Male
69
2025
26863
0.690
Why?
Chromosome Aberrations
9
2008
297
0.640
Why?
Female
65
2025
28262
0.640
Why?
Thromboembolism
3
2009
51
0.640
Why?
Neoplasm Proteins
6
2021
328
0.610
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.590
Why?
Gene Expression Profiling
19
2025
1110
0.570
Why?
Disease-Free Survival
14
2019
464
0.560
Why?
Immunoglobulin Light Chains
3
2016
90
0.550
Why?
Bone Remodeling
2
2010
154
0.550
Why?
Survival Rate
18
2019
952
0.550
Why?
Anticoagulants
5
2009
279
0.540
Why?
Blood Transfusion
1
2018
129
0.540
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
125
0.540
Why?
Immunologic Factors
5
2012
117
0.530
Why?
Cell Line, Tumor
18
2023
1436
0.510
Why?
Follow-Up Studies
21
2024
2291
0.500
Why?
Receptors, Retinoic Acid
2
2013
22
0.500
Why?
Antineoplastic Agents, Alkylating
7
2008
77
0.490
Why?
Proteasome Inhibitors
6
2018
105
0.490
Why?
Adult
39
2025
14170
0.490
Why?
IMP Dehydrogenase
2
2006
3
0.480
Why?
Mycophenolic Acid
2
2006
19
0.480
Why?
Clinical Trials as Topic
9
2022
472
0.480
Why?
Combined Modality Therapy
13
2008
639
0.460
Why?
Disease Progression
13
2025
873
0.460
Why?
Recurrence
16
2018
683
0.460
Why?
Cell Proliferation
15
2020
1029
0.460
Why?
Retrospective Studies
19
2025
6671
0.450
Why?
Antigens, Neoplasm
5
2007
147
0.450
Why?
Apoptosis
9
2019
1121
0.440
Why?
Up-Regulation
5
2020
462
0.440
Why?
Antibodies, Monoclonal
3
2015
478
0.440
Why?
Osteogenesis
3
2012
366
0.430
Why?
Animals
30
2024
13507
0.430
Why?
Venous Thromboembolism
3
2011
76
0.420
Why?
Survival Analysis
12
2021
673
0.420
Why?
Doxorubicin
8
2018
241
0.410
Why?
Signal Transduction
12
2020
1714
0.410
Why?
Bone Diseases
3
2012
95
0.400
Why?
Neoplasms, Second Primary
2
2024
77
0.390
Why?
Thrombosis
4
2012
262
0.390
Why?
T-Lymphocytes
10
2024
329
0.390
Why?
Central Nervous System Neoplasms
2
2004
69
0.380
Why?
Myeloablative Agonists
5
2014
32
0.380
Why?
Bone Marrow
7
2022
363
0.370
Why?
Oligopeptides
2
2013
92
0.370
Why?
Transplantation, Homologous
6
2004
151
0.360
Why?
Osteoblasts
4
2007
475
0.360
Why?
Hematopoietic Stem Cells
2
2010
188
0.350
Why?
Risk Factors
18
2018
3952
0.350
Why?
Meta-Analysis as Topic
2
2015
40
0.340
Why?
Salvage Therapy
9
2012
136
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.340
Why?
Tumor Microenvironment
3
2024
255
0.340
Why?
Bone Marrow Transplantation
5
2007
113
0.340
Why?
Mice
19
2024
5958
0.340
Why?
Enzyme Inhibitors
2
2019
372
0.330
Why?
Membrane Proteins
4
2017
337
0.330
Why?
Ultrasonography, Doppler
2
2007
42
0.320
Why?
Remission Induction
10
2008
219
0.320
Why?
Prospective Studies
9
2019
2457
0.320
Why?
Cell Cycle Proteins
2
2021
170
0.320
Why?
Neoplasm, Residual
4
2022
173
0.310
Why?
Myelodysplastic Syndromes
4
2007
86
0.310
Why?
B-Lymphocytes
4
2021
180
0.310
Why?
Aged, 80 and over
12
2025
3420
0.300
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.300
Why?
Lymphoma, B-Cell
3
2021
62
0.300
Why?
Neovascularization, Pathologic
1
2009
158
0.290
Why?
Immunosuppressive Agents
3
2005
250
0.290
Why?
Bone Neoplasms
1
2010
184
0.290
Why?
Killer Cells, Natural
4
2024
115
0.280
Why?
Brain Diseases, Metabolic
1
2007
5
0.270
Why?
Dose-Response Relationship, Drug
6
2016
1378
0.270
Why?
Chromosome Deletion
3
2008
141
0.270
Why?
Hyperammonemia
1
2007
24
0.270
Why?
Proteasome Endopeptidase Complex
4
2018
140
0.270
Why?
Amyloidosis
2
2007
85
0.270
Why?
Farnesyltranstransferase
1
2006
4
0.270
Why?
Research Design
1
2009
358
0.270
Why?
Thrombophilia
4
2009
19
0.270
Why?
Small Molecule Libraries
2
2019
67
0.260
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
59
0.260
Why?
Hemostasis
1
2007
61
0.260
Why?
Bone and Bones
1
2010
494
0.260
Why?
Flow Cytometry
6
2018
400
0.250
Why?
Sirolimus
1
2006
72
0.250
Why?
Cell Survival
8
2018
602
0.250
Why?
Gastrointestinal Neoplasms
1
2006
42
0.250
Why?
Immunotherapy, Adoptive
4
2024
167
0.250
Why?
Caspases
1
2006
102
0.240
Why?
In Situ Hybridization, Fluorescence
6
2016
263
0.240
Why?
Diploidy
2
2004
25
0.240
Why?
beta 2-Microglobulin
5
2008
39
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Religion
1
2005
61
0.230
Why?
Activated Protein C Resistance
4
2011
10
0.230
Why?
Case-Control Studies
10
2018
1202
0.230
Why?
Aneuploidy
1
2004
18
0.220
Why?
Enoxaparin
1
2004
31
0.220
Why?
Attitude to Health
1
2005
192
0.220
Why?
Ubiquitination
2
2021
57
0.210
Why?
Adaptation, Psychological
1
2005
229
0.210
Why?
Osteolysis
2
2022
75
0.210
Why?
Multivariate Analysis
5
2008
602
0.210
Why?
Cancer Vaccines
3
2010
78
0.210
Why?
Cisplatin
6
2009
285
0.210
Why?
Pyrimidines
3
2015
200
0.200
Why?
Cell Communication
2
2006
72
0.200
Why?
Randomized Controlled Trials as Topic
4
2012
600
0.200
Why?
Blood Coagulation
1
2003
62
0.200
Why?
Mice, Inbred NOD
6
2020
92
0.200
Why?
Antigens, CD34
1
2003
73
0.200
Why?
Critical Illness
1
2005
312
0.200
Why?
Cytogenetic Analysis
6
2007
80
0.200
Why?
Parathyroid Hormone
3
2010
151
0.190
Why?
Graft vs Host Disease
5
2010
88
0.190
Why?
Cyclophosphamide
4
2003
172
0.190
Why?
Leukemia, Myeloid
1
2002
40
0.190
Why?
STAT3 Transcription Factor
4
2015
87
0.190
Why?
Bone Resorption
2
2022
302
0.190
Why?
Kidney
1
2007
723
0.190
Why?
Chromosome Disorders
1
2002
32
0.190
Why?
Etoposide
5
2009
71
0.180
Why?
Time Factors
9
2016
3000
0.180
Why?
Hypothyroidism
1
2002
57
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.180
Why?
Logistic Models
5
2018
934
0.180
Why?
Chromosomes, Human, Pair 1
3
2006
96
0.180
Why?
Antibodies, Bispecific
1
2022
94
0.170
Why?
Neoplasm Recurrence, Local
4
2024
643
0.170
Why?
Cytotoxicity, Immunologic
3
2012
57
0.160
Why?
DNA-Binding Proteins
2
2020
426
0.160
Why?
Xenograft Model Antitumor Assays
5
2019
222
0.160
Why?
Neoplasms
2
2009
1308
0.160
Why?
Glucuronidase
2
2018
47
0.160
Why?
Predictive Value of Tests
5
2009
952
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
128
0.160
Why?
Hematologic Neoplasms
2
2016
106
0.150
Why?
Osteoclasts
4
2022
428
0.150
Why?
Syndecan-1
3
2017
73
0.150
Why?
Cytokines
4
2007
626
0.150
Why?
Kaplan-Meier Estimate
6
2015
485
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.150
Why?
Healthcare Disparities
1
2022
300
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Solvents
1
2018
33
0.150
Why?
T-Lymphocytes, Cytotoxic
3
2010
65
0.150
Why?
Pyridines
1
2019
134
0.150
Why?
Jehovah's Witnesses
1
2018
6
0.150
Why?
Dendritic Cells
3
2010
136
0.150
Why?
Vincristine
3
2003
88
0.150
Why?
Cell Differentiation
4
2022
673
0.140
Why?
Platelet Count
3
2008
76
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Iron
2
2017
129
0.140
Why?
Risk Assessment
5
2023
1350
0.140
Why?
Occupational Diseases
1
2018
85
0.140
Why?
Arsenicals
2
2010
15
0.130
Why?
Interleukin-6
2
2018
277
0.130
Why?
Pyruvate Kinase
1
2017
7
0.130
Why?
Ascorbic Acid
1
2017
25
0.130
Why?
Drug Combinations
1
2017
134
0.130
Why?
Oxides
2
2010
21
0.130
Why?
Mice, SCID
5
2018
182
0.130
Why?
Occupational Exposure
1
2018
111
0.130
Why?
RNA Splicing
1
2017
41
0.130
Why?
Anthropometry
1
2017
101
0.130
Why?
Transcription Factors
1
2020
566
0.130
Why?
Glycolysis
1
2017
73
0.130
Why?
Immunotherapy
4
2006
244
0.130
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.130
Why?
Factor V
3
2011
11
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.130
Why?
Tumor Cells, Cultured
6
2019
448
0.130
Why?
Fibrinolytic Agents
2
2007
131
0.130
Why?
Incidence
3
2009
1077
0.120
Why?
Leukocytes, Mononuclear
2
2014
122
0.120
Why?
MicroRNAs
1
2020
388
0.120
Why?
Reproductive History
1
2015
4
0.120
Why?
Oncolytic Virotherapy
1
2015
21
0.120
Why?
Hormone Replacement Therapy
1
2015
21
0.120
Why?
Cyclopentanes
1
2015
12
0.120
Why?
Ubiquitins
1
2015
19
0.120
Why?
Cell Adhesion Molecules
1
2015
88
0.120
Why?
Hemorrhage
2
2007
224
0.120
Why?
Postmenopause
1
2015
81
0.120
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
113
0.120
Why?
Aldehyde Dehydrogenase
1
2014
25
0.120
Why?
NF-kappa B
3
2018
329
0.110
Why?
Intestines
1
2016
154
0.110
Why?
Drug Monitoring
1
2015
83
0.110
Why?
Leukapheresis
1
2014
19
0.110
Why?
Protein-Tyrosine Kinases
1
2015
89
0.110
Why?
Translocation, Genetic
3
2005
265
0.110
Why?
Transplantation Chimera
3
2003
16
0.110
Why?
Myeloma Proteins
2
2020
26
0.110
Why?
Gene Deletion
3
2004
275
0.110
Why?
Antibodies
2
2024
150
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
506
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Body Mass Index
1
2017
692
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.110
Why?
Isoxazoles
1
2013
15
0.100
Why?
Sulfones
1
2013
24
0.100
Why?
Biopsy
2
2006
607
0.100
Why?
Hedgehog Proteins
1
2013
34
0.100
Why?
Cystatin M
2
2024
19
0.100
Why?
Itraconazole
1
2013
38
0.100
Why?
Metaphase
3
2008
46
0.100
Why?
Genetic Predisposition to Disease
1
2016
528
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Carrier Proteins
2
2017
320
0.100
Why?
Wnt Proteins
1
2013
102
0.100
Why?
B-Cell Maturation Antigen
2
2024
98
0.100
Why?
Renal Insufficiency
3
2009
115
0.100
Why?
Risk
2
2011
313
0.100
Why?
Infusions, Intravenous
2
2003
222
0.100
Why?
Viremia
1
2012
23
0.100
Why?
Drug Delivery Systems
2
2005
148
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
55
0.100
Why?
Cytomegalovirus Infections
1
2012
36
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
Why?
Radiopharmaceuticals
2
2021
205
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Receptors, KIR
2
2008
12
0.090
Why?
Phosphorylation
2
2020
530
0.090
Why?
Fluorodeoxyglucose F18
2
2021
188
0.090
Why?
Medical Oncology
1
2012
104
0.090
Why?
Reoperation
2
2004
465
0.090
Why?
Ligands
2
2009
207
0.090
Why?
Drug Evaluation, Preclinical
1
2012
142
0.090
Why?
Alcohol Drinking
1
2013
238
0.090
Why?
Inflammation
1
2016
644
0.090
Why?
Age Factors
3
2005
1132
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Smoking
1
2014
518
0.090
Why?
Tretinoin
2
2009
53
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
496
0.090
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
Why?
Down-Regulation
2
2010
344
0.080
Why?
MAP Kinase Kinase 1
1
2010
23
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Macrophages
1
2013
379
0.080
Why?
Authorship
1
2010
12
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Neoplasm Staging
3
2015
768
0.080
Why?
Bone Density Conservation Agents
1
2010
75
0.080
Why?
Conflict of Interest
1
2010
26
0.080
Why?
Drug Industry
1
2010
40
0.080
Why?
Disclosure
1
2010
41
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Mice, Transgenic
3
2021
564
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
73
0.080
Why?
Plasmacytoma
2
2011
43
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
412
0.080
Why?
Periodicals as Topic
1
2010
61
0.080
Why?
Cell Cycle
2
2010
240
0.080
Why?
Magnetic Resonance Imaging
3
2007
1545
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
593
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
187
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Prednisone
2
2009
102
0.070
Why?
Pulmonary Embolism
1
2009
85
0.070
Why?
Polyethylene Glycols
1
2008
90
0.070
Why?
Sulfonamides
1
2009
134
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
582
0.070
Why?
Neutrophils
2
2014
148
0.070
Why?
Immunophenotyping
2
2007
117
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Hemoglobins
1
2008
111
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
23
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
132
0.070
Why?
Histocompatibility Antigens Class I
1
2007
48
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Fibrinolysis
1
2007
6
0.070
Why?
Blood Coagulation Factors
1
2007
18
0.070
Why?
Ammonia
1
2007
86
0.070
Why?
Serum Albumin
2
2008
58
0.070
Why?
Chi-Square Distribution
1
2007
295
0.070
Why?
Cell Membrane
1
2007
242
0.060
Why?
Biomedical Research
1
2010
258
0.060
Why?
Brain
2
2007
1325
0.060
Why?
Drug Administration Schedule
2
2006
376
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Models, Genetic
1
2006
172
0.060
Why?
Guanosine
1
2006
7
0.060
Why?
Antibiotics, Antineoplastic
1
2006
79
0.060
Why?
Sex Factors
3
2016
729
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Renal Dialysis
1
2007
191
0.060
Why?
Survivors
1
2006
118
0.060
Why?
Guanosine Triphosphate
1
2004
17
0.060
Why?
Karyotyping
1
2005
78
0.060
Why?
Gene Duplication
1
2005
16
0.060
Why?
Neovascularization, Physiologic
1
2005
87
0.060
Why?
Oncogene Proteins, Fusion
1
2005
60
0.060
Why?
Tissue Donors
2
2003
126
0.060
Why?
ROC Curve
1
2025
254
0.060
Why?
Kidney Transplantation
1
2007
200
0.060
Why?
Proteolysis
2
2015
102
0.060
Why?
Thrombophlebitis
1
2004
18
0.060
Why?
Genomic Instability
1
2005
89
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Neoplastic Cells, Circulating
1
2004
34
0.050
Why?
RNA Interference
2
2015
186
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
336
0.050
Why?
Patient Selection
1
2005
266
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Confidence Intervals
1
2003
159
0.050
Why?
Probability
1
2003
173
0.050
Why?
Interferons
1
2002
37
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
144
0.050
Why?
Anxiety
1
2005
301
0.050
Why?
Cyclosporine
1
2003
67
0.050
Why?
Drug Therapy, Combination
2
2017
400
0.050
Why?
Transcriptome
1
2025
368
0.050
Why?
Geography
1
2022
66
0.050
Why?
Thyroid Function Tests
1
2002
27
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
Tacrolimus
1
2003
60
0.050
Why?
Stromal Cells
1
2002
77
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Administration, Oral
1
2003
455
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
205
0.050
Why?
Fatal Outcome
1
2002
196
0.050
Why?
Genomics
1
2023
270
0.050
Why?
Chromosome Mapping
3
2006
151
0.050
Why?
Cell Division
1
2002
288
0.050
Why?
RANK Ligand
1
2022
187
0.040
Why?
Graft Survival
1
2002
161
0.040
Why?
Cells, Cultured
1
2005
1588
0.040
Why?
Acute Disease
1
2002
387
0.040
Why?
Cluster Analysis
3
2006
233
0.040
Why?
Tomography, X-Ray Computed
1
2006
1162
0.040
Why?
Young Adult
3
2015
4337
0.040
Why?
Pain
1
2003
362
0.040
Why?
Neoplasm Transplantation
1
2020
86
0.040
Why?
Depression
1
2005
604
0.040
Why?
Odds Ratio
2
2016
568
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Staphylococcal Infections
1
2003
280
0.040
Why?
Postoperative Complications
1
2007
1081
0.040
Why?
Positron-Emission Tomography
1
2021
303
0.040
Why?
Crystallography, X-Ray
1
2019
156
0.040
Why?
Antigens, CD
2
2015
216
0.040
Why?
Mice, Nude
1
2019
235
0.040
Why?
Protein Conformation
1
2019
179
0.040
Why?
Bone Marrow Cells
2
2015
190
0.040
Why?
Coculture Techniques
2
2012
145
0.040
Why?
Mice, Inbred BALB C
1
2019
310
0.040
Why?
Receptors, Interleukin-6
1
2018
23
0.040
Why?
Antigens, CD19
1
2018
28
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Drug Resistance
1
2018
68
0.040
Why?
Disease Management
1
2020
188
0.040
Why?
Interferon-gamma
2
2010
179
0.040
Why?
Protein Stability
1
2018
46
0.040
Why?
Gene Knockdown Techniques
1
2018
110
0.040
Why?
Epidemiologic Methods
2
2008
46
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Microfilament Proteins
1
2017
44
0.030
Why?
HLA-A Antigens
2
2007
11
0.030
Why?
Cross-Sectional Studies
1
2022
1686
0.030
Why?
Transplantation, Heterologous
1
2017
78
0.030
Why?
Calcium-Binding Proteins
1
2017
58
0.030
Why?
Thyroid Hormones
1
2017
22
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
53
0.030
Why?
Vaccination
2
2010
299
0.030
Why?
Genetic Loci
1
2016
49
0.030
Why?
Protein Binding
1
2018
673
0.030
Why?
Antibodies, Neoplasm
2
2006
27
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Microscopy, Electron, Transmission
1
2015
70
0.030
Why?
Mice, Knockout
1
2018
910
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Genome-Wide Association Study
1
2016
187
0.030
Why?
Tumor Burden
1
2016
136
0.030
Why?
Repressor Proteins
1
2016
154
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Disease Models, Animal
2
2013
1486
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
RNA, Messenger
2
2010
1139
0.030
Why?
Models, Biological
1
2018
741
0.030
Why?
Family
1
2016
174
0.030
Why?
Adenine
1
2015
31
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Molecular Targeted Therapy
1
2016
134
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Reactive Oxygen Species
1
2017
422
0.030
Why?
Cell Lineage
1
2014
88
0.030
Why?
Drug Synergism
1
2014
148
0.030
Why?
Mitosis
1
2014
89
0.030
Why?
beta Catenin
1
2015
103
0.030
Why?
Piperidines
1
2015
96
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
136
0.030
Why?
Pyrazoles
1
2015
114
0.030
Why?
Cell Movement
1
2015
276
0.030
Why?
Proportional Hazards Models
2
2006
444
0.030
Why?
Patient Safety
1
2014
104
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
24
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Membrane Glycoproteins
2
2006
242
0.030
Why?
Epitopes
1
2013
62
0.030
Why?
Adolescent
2
2014
6737
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
47
0.020
Why?
Protein Kinase Inhibitors
1
2014
228
0.020
Why?
Immunoglobulin M
1
2012
60
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
Why?
Cytomegalovirus
1
2012
30
0.020
Why?
Viral Load
1
2012
80
0.020
Why?
Interleukin-2
1
2012
69
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Peripheral Nervous System Diseases
1
2012
59
0.020
Why?
Immunoenzyme Techniques
1
2012
136
0.020
Why?
Arkansas
2
2008
2029
0.020
Why?
Viper Venoms
1
2011
6
0.020
Why?
Lymphocyte Activation
1
2012
163
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Neoadjuvant Therapy
1
2012
125
0.020
Why?
Chemotherapy, Adjuvant
1
2011
124
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
177
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
CD40 Ligand
1
2010
15
0.020
Why?
Interleukin-4
1
2010
44
0.020
Why?
Immunity, Cellular
1
2010
64
0.020
Why?
Adjuvants, Immunologic
1
2010
52
0.020
Why?
Diagnosis, Differential
2
2004
1048
0.020
Why?
Mutation
1
2015
1344
0.020
Why?
Physician's Role
1
2010
50
0.020
Why?
RNA, Small Interfering
1
2010
218
0.020
Why?
Education, Medical, Continuing
1
2010
72
0.020
Why?
Practice Guidelines as Topic
1
2012
496
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Protein Isoforms
1
2009
125
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Safety
1
2009
80
0.020
Why?
Vasculitis
1
2008
28
0.020
Why?
Algorithms
1
2012
668
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
94
0.020
Why?
Twins
1
2007
33
0.020
Why?
Double-Blind Method
1
2009
718
0.020
Why?
Age Distribution
1
2007
175
0.020
Why?
C-Reactive Protein
1
2008
152
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Creatinine
1
2007
159
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
14
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Heterozygote
1
2006
91
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Amiloride
1
2005
7
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Transduction, Genetic
1
2005
44
0.020
Why?
Cell Line
1
2008
1033
0.020
Why?
Radiography
1
2007
474
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.010
Why?
Data Interpretation, Statistical
1
2006
164
0.010
Why?
Neoplasms, Experimental
1
2006
112
0.010
Why?
Sensitivity and Specificity
1
2007
883
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Monocytes
1
2005
129
0.010
Why?
Databases, Factual
1
2007
715
0.010
Why?
Clone Cells
1
2004
76
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
237
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
Fibroblasts
1
2005
359
0.010
Why?
History, 21st Century
1
2003
59
0.010
Why?
History, 20th Century
1
2003
96
0.010
Why?
Interphase
1
2003
10
0.010
Why?
Plasmapheresis
1
2003
12
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
5227
0.010
Why?
Perforin
1
2002
12
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
11
0.010
Why?
Antigen Presentation
1
2002
26
0.010
Why?
Anemia
1
2003
74
0.010
Why?
Cohort Studies
1
2006
1553
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Prevalence
1
2005
1017
0.010
Why?
Erythrocyte Transfusion
1
2002
53
0.010
Why?
Cell Culture Techniques
1
2002
99
0.010
Why?
DNA, Neoplasm
1
2002
146
0.010
Why?
Graft Rejection
1
2002
179
0.010
Why?
Kidney Diseases
1
2003
231
0.010
Why?
Anti-Bacterial Agents
1
2003
803
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description